Compared to patients with HSD17B13 wild–type A/A (212 cases) and variants (A/AA or AA/AA, 190 cases), there were no significant differences in the age, sex distribution, BMI, ALD, or prevalence of diabetes or dyslipidemia. This evidence concerns the gene HSD17B13 and metabolic syndrome.